Jason Witherington

USPTO Granted Patents = 16 (Patent Applications = 4)

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 2)

Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 88(Granted Patents)

Location History:

Reading, GB (1998)
Sawbridgeworth, GB (2003)
Harlow, GB (1998 - 2012)
Stevenage, GB (2012 - 2017)

Company Filing History:

Smithkline Beecham Corporation

Mitsubishi Tanabe Pharma Corporation

patents

5. 1 out of 10

University of Reading

patents

6. 2 out of 832,680

Other

patents

Years Active: 1998-2017

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9598420 - Benzodiazepine bromodomain inhibitor (2017-03-21),

2. 9102677 - Benzodiazepine bromodomain inhibitor (2015-08-11),

3. 8222245 - Oxadiazole derivatives active on sphingosine-1-phosphate (S1P) (2012-07-17),

4. 8207331 - Benzazepine derivatives for the treatment of neurological disorders (2012-06-26),

5. 7799773 - Benzazepine derivatives for the treatment of neurological disorders (2010-09-21),

6. 7704994 - Benzazepine derivatives for the treatment of neurological disorders (2010-04-27),

7. 7696193 - Benzazepine derivatives for the treatment of neurological disorders (2010-04-13),

8. 7410984 - Compounds (2008-08-12),

9. 7381728 - Piperazine derivatives useful for the treatment of gastrointestinal disorders (2008-06-03),

10. 7348339 - Imidazopyridine derivatives as kinase inhibitors (2008-03-25),

11. 7297792 - Pyrazolopyridines and pyrazolopyridazines as antidiabetics (2007-11-20),

12. 7109199 - Pyrazolopyridines and pyrazolopyridazines as antidiabetics (2006-09-19),

13. 7105532 - Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors (2006-09-12),

14. 6566373 - Protease inhibitors (2003-05-20),

15. 5750805 - Rearrangement of epoxides (1998-05-12),

Title: Jason Witherington: A Visionary Inventor from Harlow, GB

Introduction:

Jason Witherington is a visionary inventor hailing from Harlow, GB, known for his remarkable contributions to the world of technology. With 16 patents to his name and a relentless pursuit of innovation, he continues to inspire the next generation of inventors and entrepreneurs.

Latest Patents:

Among his latest patents is the "Benzodiazepine bromodomain inhibitor," which includes compounds of formula (I) and salts thereof. These pharmaceutical compositions have shown promising results in therapy, showcasing Jason's innovative approach to medical advancements.

Career Highlights:

Throughout his career, Jason has made significant strides in the field of technology and pharmaceuticals. He has worked with renowned companies such as Glaxo Group Limited and SmithKline Beecham Corporation, where he has played a key role in developing cutting-edge solutions.

Collaborations:

In his journey towards innovation, Jason has collaborated closely with esteemed professionals in the industry. Notable coworkers include David Matthew Wilson and Sanjeet Singh Sehmi, who have contributed to the success of various projects alongside Jason.

Conclusion:

In conclusion, Jason Witherington stands as a visionary inventor whose dedication to pushing the boundaries of what is possible has left a lasting impact on the world of technology. His innovative spirit and remarkable contributions serve as a testament to his unwavering commitment to shaping the future of invention and entrepreneurship.

This text is generated by artificial intelligence and may not be accurate.